Human oral keratinocytes: a model system to analyze host-pathogen interactions

Torsten Wöllert1, Christiane Rollenhagen, George M Langford

  • 1Department of Biology, Syracuse University, Syracuse, NY, USA.

Insights

This study presents an in vitro model using human oral keratinocytes to investigate host-pathogen interactions with Candida albicans. This research offers insights into cellular responses to fungal infections and potential therapeutic targets.

Area of Science:

  • Microbiology
  • Cell Biology
  • Immunology

Background:

  • Host-pathogen interactions are crucial in determining infection outcomes.
  • Fungal infections, particularly Candida albicans, pose significant clinical challenges, especially in vulnerable patients.
  • Understanding host responses is key to combating these infections.

Purpose of the Study:

  • To establish and describe an in vitro assay for studying human oral keratinocyte responses to Candida albicans.
  • To characterize dynamic cellular changes during host-fungal interactions.
  • To identify potential drug targets for treating fungal infections.

Main Methods:

  • Utilized an in vitro model with human oral keratinocytes (OKF6/TERT-2).
  • Introduced the pathogenic fungus Candida albicans to the cell culture.
  • Employed epifluorescence deconvolution microscopy to monitor cellular changes and differentiation markers.
  • Analyzed immunofluorescence data using linescan analysis and fluorescence intensity measurements to quantify protein expression.

Main Results:

  • Successfully characterized the dynamic cellular responses of oral keratinocytes to Candida albicans.
  • Quantified changes in protein expression levels indicative of host cell reaction.
  • Demonstrated the utility of the in vitro model for studying host-pathogen dynamics.

Conclusions:

  • The developed in vitro model provides valuable insights into host cell behavior during Candida albicans infection.
  • This model system can advance the understanding of fungal pathogenesis.
  • The findings pave the way for identifying novel therapeutic strategies and drug targets.